Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1994-09-16
1996-03-19
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514 82, 514 89, 514553, 549220, 546 22, 546 23, A61K 31665, C07F 930, C07D22100
Patent
active
055004180
ABSTRACT:
Compounds of formula I ##STR1## wherein R is diethoxymethyl, R.sub.1 is hydrogen, R.sub.2 is pyrid-3-ylmethyl and R.sub.3 is hydrogen, or R is cyclohexylmethyl, R.sub.1 is hydrogen and R.sub.2 is quinolin-4-ylmethyl, or R.sub.1 is hydroxy and R.sub.2 is 3,4-methylenedioxybenzyl, 1-(3,4-methylenedioxyphenyl)ethyl, and R.sub.3 is hydrogen, or R is benzyl, R.sub.1 is hydroxy, R.sub.2 is 1-(3,4-methylenedioxyphenyl)ethyl, and R.sub.3 is hydrogen, and salts thereof have GABA.sub.B -antagonistic properties and can be used for the treatment of diseases responsive to GABA.sub.B -antagonists.
REFERENCES:
patent: 4536355 (1985-08-01), Lee et al.
patent: 4618358 (1986-10-01), Maier
patent: 4656298 (1987-04-01), Dingwall et al.
patent: 4772738 (1988-09-01), Dingwall et al.
patent: 4908465 (1990-03-01), Dingwall et al.
patent: 5004826 (1991-04-01), Dingwall et al.
patent: 5013863 (1991-05-01), Baylis et al.
patent: 5039685 (1991-08-01), Knutsen et al.
patent: 5051524 (1991-09-01), Baylis et al.
patent: 5064819 (1991-11-01), Baylis et al.
patent: 5071859 (1991-12-01), Knudsen et al.
patent: 5190933 (1993-03-01), Baylis et al.
patent: 5190934 (1993-03-01), Mickel et al.
patent: 5229379 (1993-07-01), Marescaux et al.
patent: 5243062 (1993-09-01), Dingwall et al.
patent: 5281747 (1994-01-01), Hall et al.
patent: 5300679 (1994-04-01), Baylis et al.
patent: 5332729 (1994-07-01), Mickel et al.
patent: 5376684 (1994-12-01), Mickel
patent: 5407922 (1995-04-01), Marescaux et al.
patent: 5424441 (1995-06-01), Mickel et al.
J. Neural Transm (1992) [Suppl] 35: 37-69 Marescaux et al, Genetic absence epilepsy in rats from Strasbourg--A review.
Hosford et al "Anatomic Distribution of the Immediate--Early Gene C-Fos in Amygdala Kingling" Annual Meeting of the American Academy of Neurology Boston Mass. Apr. 20-27 (1991) Neurology 41--(Suppl) p. 151 Abstract No. 1 130 S. Mar. 1991.
J. G. Dingwall "New Carboxyphosphonic and phosphinic Acid Structures of Technical and Biological Interest" Phosphorous and Sulfur v. 18. (353-6) 1983.
Walter et al "Herbicidal Methylphosphinic Acid Derivatives" Chem. Abs. vol. 97: 72585v (1982).
Hosford et al "The Lethargic Mouse. A genetic Model of Absence Epilepsy" 21st Annual Meeting New Orleans Louisiana. Nov. 10-15 1991 Society for Neuroscience--Abstract p. 170 vol. 17--(1991).
Neuroscience Letters. 33 (1982) 97-101 Vergnes et al Spontaneous Paroxysmal Electroclinical Patterns in Ral: A Model of Generalized Non-Convulsive Epilepsy.
Ciba-Geigy Corporation
Fishman Irving M.
Ivy C. Warren
Kaiser Karen
Owens Amelia
LandOfFree
Aminoalkanephosphinic acids and salts thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aminoalkanephosphinic acids and salts thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminoalkanephosphinic acids and salts thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1959442